Private credit's new frontier is the balance sheet

PGIM has put $3 billion behind GreenSky home-improvement loans. The facility is a three-year forward-flow arrangement. Crestline Investors has closed its second European capital solutions fund at $625 million. That is nearly three-quarters above its predecessor. The two announcements come from different corners of the credit market. PGIM's is a consumer finance arrangement tied to the US housing value chain. Crestline's is a closed-end fund for collateral-backed lending to Europe's lower middle market. Beneath the labels, they are the same trade: private credit managers moving from underwriting corporate cash flows to financing specific asset pools.

The PGIM facility sits on the firm's asset-based finance platform at the consumer end of the housing value chain. A forward-flow structure means PGIM is not underwriting a single company's EBITDA or relying on a sponsor's equity cushion. The credits underneath are home-improvement receivables, and the commitment runs for three years. The size, structure, and asset class are what matter: $3 billion, forward flow, consumer housing-related receivables.

Crestline's vehicle is a fund close, not a single facility. It raised $625 million for its second European capital solutions strategy. That is nearly three-quarters more than Fund I. The capital is earmarked for collateral-backed lending in Europe's lower middle market. The loans are secured by specific assets, not by the promise of a company's future profits. The first fund's size is not disclosed, but the final close suggests limited partners were willing to re-up and increase their commitment.

Both deals lean on the balance sheet. In both cases, the lender's first line of defense is a defined pool of assets. With GreenSky, that pool is home-improvement loans. With Crestline, it is collateral held against loans to smaller European companies. Traditional unitranche underwriting starts with a borrower's cash flow, financial projections, and enterprise value. Asset-based finance starts with the collateral, the advance rate, and the servicing.

The two disclosures tackle the asset-based finance opportunity from opposite ends. PGIM is using a forward flow with an established consumer finance name, deploying capital continuously as loans are originated. Crestline is using a committed fund that will source collateral-backed transactions across a region. The result is the same: capital is moving toward asset pools, not corporate income statements.

Managers have reason to build this capability now. Sponsor-backed direct lending has grown crowded, and the spread premium for plain-vanilla cash-flow loans has narrowed relative to other opportunities. Asset-based finance offers a different pool of risk, often with shorter duration, amortization, and specific collateral. That does not make it safer. It is a different risk; for an allocator, that difference is the point.

Geography matters, too. US consumer housing finance is a deep, established market where forward flow can be scaled. Europe's lower middle market is more fragmented, and collateral enforcement varies by jurisdiction. Crestline's fund is a bet that the fragmentation is an opportunity, not just a cost. PGIM's facility is a bet that US consumer receivables can be originated at scale and financed continuously.

That shift has consequences for direct lending. If more managers can raise funds for asset-based strategies, some of the marginal dollar that once flowed into sponsor-backed cash-flow loans will instead compete for consumer receivables, equipment leases, mortgage pools, and trade finance assets. Pricing effects will be uneven. Consumer and SME collateral can be re-underwritten more quickly than a corporate loan, but it comes with servicing risk and a different loss curve. A manager can model the collateral; it still has to collect.

The forward-flow structure and the closed-end fund operate differently. A forward flow commits the manager to buy assets as a lender produces them, locking in a pipeline instead of doing one-off deals. A closed-end fund raises committed capital first, then sources collateral-backed loans. Both share a trait that matters: returns depend on asset selection and servicing, not on a borrower's ability to grow EBITDA.

None of this makes asset-based finance a free option. Consumer receivables depend on borrower payment behavior and home-improvement spending cycles. Collateral-backed SME loans depend on the quality of the collateral and the ability to enforce it across European jurisdictions. Collateral does not eliminate loss; it shifts where loss shows up. The question for allocators is whether the yield compensates for that shift.

For an allocator, the two deals require different due diligence. Consumer forward flow demands confidence in the originator's underwriting standards and servicing. A European collateral-backed fund demands confidence in the manager's ability to source and enforce collateral across markets. In both cases, the manager is not asking the allocator to trust a company's budget; it is asking the allocator to trust the value of a pool.

For allocators, the two announcements make plain that private credit is no longer a single strategy. The Crestline close shows demand for a European collateral-backed vehicle at nearly three-quarters above its predecessor. The PGIM facility shows a manager committing $3 billion to consumer home-improvement loans. Both are bets that asset-based finance can deliver returns without the same concentration in large corporate credit that now dominates direct-lending portfolios.

The two deals matter beyond their individual headlines. They mark a broader turn in private credit: managers that built their books on corporate cash-flow lending are now building asset-based finance platforms to keep deploying capital. The Crestline fund's size relative to its predecessor shows the allocator community is willing to fund that turn. PGIM's $3 billion facility shows the turn is being executed at scale, not as a pilot.

The next test will come when consumer credit and SME collateral are stressed. At that point, the difference between underwriting an asset pool and underwriting a company's income statement will show up in recovery rates, servicing costs, and the speed at which managers can move. The two deals have not answered that question. They have simply made it more urgent.